A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01822899 · COMPLETED
Trial details
- NCT number
- NCT01822899
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-04
- Primary completion
- 2013-10-01
- Enrollment
- 717
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.